Literature DB >> 27318493

Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough?

Andrea Papadia1, Sara Imboden2, Maria Luisa Gasparri2,3, Franziska Siegenthaler2, Anja Fink2, Michael D Mueller2.   

Abstract

PURPOSE: The adoption of a sentinel lymph node (SLN) algorithm and the presence of high bilateral detection rates have been associated with increased accuracy of SLN mapping in cervical and endometrial cancer patients. In this context, the significance of the number of SLNs removed has not yet been investigated. The aim of this study was to evaluate (a) whether or not a higher SLN removal count is associated with a reduced false-negative rate and (b) which clinical factors correlate with the number of SLNs removed.
METHODS: Patients with cervical or endometrial cancer who underwent SLN mapping with bilateral SLN detection followed by lymphadenectomy were evaluated retrospectively. On the basis of the mean number of the SLNs removed, the patients were divided in two groups: Group 1 included patients with up to 3 SLNs removed and Group 2 included patients with more than 3 SLNs removed. Factors predicting a higher SLN count were evaluated using univariate and multivariate analysis.
RESULTS: Eighty-four patients met the inclusion criteria. The two groups consisted of 42 patients each and differed only by the median SLN count. Two endometrial cancer patients in Group 1 had false-negative pelvic SLNs and isolated para-aortic metastases; no false-negative SLNs were recorded in Group 2 (p = n.s.). The results of multivariate analysis indicted that the number of SLNs removed was influenced only in cases where the operating surgeon had performed more than 20 laparoscopic ICG SLN mappings.
CONCLUSIONS: A higher SLN count does not seem to increase the accuracy of SLN mapping in cervical and endometrial cancer patients.

Entities:  

Keywords:  Cervical cancer; Echelon lymph nodes; Endometrial cancer; Indocyanine green; Sentinel lymph node count; Sentinel lymph node mapping

Mesh:

Substances:

Year:  2016        PMID: 27318493     DOI: 10.1007/s00432-016-2193-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  37 in total

1.  Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.

Authors:  J How; W H Gotlieb; J Z Press; J Abitbol; M Pelmus; A Ferenczy; S Probst; R Gotlieb; S Brin; S Lau
Journal:  Gynecol Oncol       Date:  2015-04-12       Impact factor: 5.482

Review 2.  Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis.

Authors:  Ilary Ruscito; Maria Luisa Gasparri; Elena Ioana Braicu; Filippo Bellati; Luigi Raio; Jalid Sehouli; Michael D Mueller; Pierluigi Benedetti Panici; Andrea Papadia
Journal:  Ann Surg Oncol       Date:  2016-05-09       Impact factor: 5.344

3.  Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.

Authors:  Matteo Morotti; Mario Valenzano Menada; Melita Moioli; Paolo Sala; Ilaria Maffeo; Luca Abete; Ezio Fulcheri; Stefania Menoni; Pierluigi Venturini; Andrea Papadia
Journal:  Gynecol Oncol       Date:  2012-02-21       Impact factor: 5.482

4.  A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer.

Authors:  Sanjeev Kumar; Fabiola Medeiros; Sean C Dowdy; Gary L Keeney; Jamie N Bakkum-Gamez; Karl C Podratz; William A Cliby; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2012-08-29       Impact factor: 5.482

5.  Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.

Authors:  Edward J Tanner; Abdulrahman K Sinno; Rebecca L Stone; Kimberly L Levinson; Kara C Long; Amanda N Fader
Journal:  Gynecol Oncol       Date:  2015-06-19       Impact factor: 5.482

6.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

7.  Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.

Authors:  Amit Goyal; Robert G Newcombe; Alok Chhabra; Robert E Mansel
Journal:  Breast Cancer Res Treat       Date:  2006-03-16       Impact factor: 4.872

8.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

9.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

10.  Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.

Authors:  Andrea Papadia; Sara Imboden; Franziska Siegenthaler; Maria Luisa Gasparri; Stefan Mohr; Susanne Lanz; Michael D Mueller
Journal:  Ann Surg Oncol       Date:  2016-01-20       Impact factor: 5.344

View more
  12 in total

Review 1.  Surgical staging in endometrial cancer.

Authors:  Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-20       Impact factor: 4.553

2.  The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Sophie Genoud; Klaeser Bernd; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-01       Impact factor: 4.553

Review 3.  Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-21       Impact factor: 4.553

Review 4.  New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer.

Authors:  Diego Rossetti; Salvatore Giovanni Vitale; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-05-02

5.  FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?

Authors:  Andrea Papadia; Maria Luisa Gasparri; Franziska Siegenthaler; Sara Imboden; Stefan Mohr; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-11       Impact factor: 4.553

6.  Identification of the Thoracic Duct Using Indocyanine Green During Cervical Lymphadenectomy.

Authors:  Jeffery Chakedis; Lawrence A Shirley; Alicia M Terando; Roman Skoracki; John E Phay
Journal:  Ann Surg Oncol       Date:  2018-08-03       Impact factor: 5.344

7.  Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Anda P Radan; Chantal A L Stämpfli; Tilman T Rau; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-24       Impact factor: 4.553

8.  The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.

Authors:  Andrea Papadia; Alessandro Buda; Maria Luisa Gasparri; Giampaolo Di Martino; Beatrice Bussi; Debora Verri; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-24       Impact factor: 4.553

9.  Exploratory Study of the Clinical Value of Near-Infrared Sentinel Lymph Node Mapping With Indocyanine Green in Vulvar Cancer Patients.

Authors:  Franziska Siegenthaler; Sara Imboden; Laura Knabben; Stefan Mohr; Andrea Papadia; Michael D Mueller
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

10.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.